Search - tctmd.com

Displaying 1 - 20 of 163

Sort: Relevancy | Date

Presentation TCT 2025

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Presenter: Sahil A. Parikh

October 28, 2025

Presentation TCT 2025

HOPE Registry: Updates on the 3 year results of BTK subset analyses

Presenter: Edward Tieng Chek Choke

October 28, 2025

Presentation TCT 2025

TCT 199: Use of the Esprit BTK Biodegradable Stent Scaffold for Recurrent Coronary In-stent Restenosis

Presenter: Bilal M. Murad

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

TCT 914: Impact of Visual Estimation versus Quantitative Coronary Angiography of Diameter Stenosis on Clinical Outcomes in the LIFE-BTK Trial

Presenter: Hector M. Garcia-Garcia

October 27, 2025

Presentation TCT 2025

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

Lesion Preparation Throwdown: BTK Cases When I like Specialty Balloons

Presenter: Michael Cyrus Siah

October 26, 2025

Presentation TCT 2025

Lesion Preparation Throwdown: BTK Cases When I use Atherectomy?

Presenter: Anvar Babaev

October 26, 2025

Presentation TCT 2025

Lesion Preparation Throwdown – BTK Cases When I Use Javelin or IVL?

Presenter: John Winscott

October 26, 2025

Presentation TCT 2025

State of the Art BTK Drug Delivery: Do We Know What Works and When Will We Have the Evidence?

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

DCBs BTK – Where are They Now? (Current Update)

Presenter: Eric A. Secemsky

October 26, 2025

Presentation TCT 2025

BTK Scaffolds – From Esprit to Reflow: What Does it Mean to Be a Scaffold (Case Examples)?

Presenter: S. Jay Mathews

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

Real-World Study of IVL in Challenging BTK Lesions: Acute Results of the Disrupt BTK II Study

Presenter: Sahil Parikh

October 29, 2024

Advertisement

Insights into PAD Pathogenesis from LIFE-BTK Substudies

HOPE Registry: Updates on the 3 year results of BTK subset analyses

TCT 199: Use of the Esprit BTK Biodegradable Stent Scaffold for Recurrent Coronary In-stent Restenosis

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

TCT 914: Impact of Visual Estimation versus Quantitative Coronary Angiography of Diameter Stenosis on Clinical Outcomes in the LIFE-BTK Trial

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Lesion Preparation Throwdown: BTK Cases When I like Specialty Balloons

Lesion Preparation Throwdown: BTK Cases When I use Atherectomy?

Lesion Preparation Throwdown – BTK Cases When I Use Javelin or IVL?

State of the Art BTK Drug Delivery: Do We Know What Works and When Will We Have the Evidence?

DCBs BTK – Where are They Now? (Current Update)

BTK Scaffolds – From Esprit to Reflow: What Does it Mean to Be a Scaffold (Case Examples)?

What’s Going to Be Hot at TCT 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Top Endovascular News of 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Real-World Study of IVL in Challenging BTK Lesions: Acute Results of the Disrupt BTK II Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content